Telesis Bio to Present at Jefferies Healthcare Conference 2023
June 08, 2023 09:05 ET
|
Telesis Bio
SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, announced that Todd R. Nelson, Ph.D., CEO and Founder...
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
June 06, 2023 03:00 ET
|
Telesis Bio
SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their...
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
June 05, 2023 17:30 ET
|
Telesis Bio
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced...
Telesis Bio Secures Financing of $28.0 Million
May 31, 2023 17:29 ET
|
Telesis Bio
Up to an Additional $46.2 Million Available Through Warrant Exercise Led by Novalis LifeSciences LLC with participation from Northpond Ventures, M-185 Corporation and BroadOak Capital Partners SAN...
Telesis Bio to Present at SynBioBeta 2023
May 23, 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop...
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
May 22, 2023 12:00 ET
|
Telesis Bio
SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
May 18, 2023 10:00 ET
|
Telesis Bio
SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
May 15, 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop...
Telesis Bio Reports First Quarter 2023 Financial Results
May 11, 2023 16:05 ET
|
Telesis Bio
-- Total revenue of $6.3M in 1QFY23 -- BioXp® franchise revenue increased by 28% SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and...
Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
April 27, 2023 16:05 ET
|
Telesis Bio
SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its first quarter...